Monte Rosa Therapeutics, Inc.GLUENASDAQ
Loading
Interest Income Over TimeExpanding
Percentile Rank100
3Y CAGR+50.9%
5Y CAGR+328.1%
Year-over-Year Change
Income earned from interest-bearing assets
3Y CAGR
+50.9%/yr
Annual compound
5Y CAGR
+328.1%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
1438x
Strong expansion
Streak
6 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $12.94M | +22.5% |
| 2024 | $10.57M | +13.2% |
| 2023 | $9.33M | +148.0% |
| 2022 | $3.76M | +8082.6% |
| 2021 | $46000.00 | +411.1% |
| 2020 | $9000.00 | +74900.0% |
| 2019 | $12.00 | - |